Ensysce Biosciences (ENSC) Institutional Ownership $2.31 +0.04 (+1.54%) Closing price 07/3/2025 03:43 PM EasternExtended Trading$2.31 0.00 (0.00%) As of 07/3/2025 04:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Ensysce Biosciences (NASDAQ:ENSC)CurrentInstitutional OwnershipPercentage5.63%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$4.37MNumber ofInstitutional Sellers(last 12 months)0 Get ENSC Insider Trade Alerts Want to know when executives and insiders are buying or selling Ensysce Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ENSC Institutional Buying and Selling by Quarter Ensysce Biosciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/16/2025Murchinson Ltd.140,000$358K0.0%N/A5.905% 5/16/2025Adage Capital Partners GP L.L.C.74,711$191K0.0%+49.4%3.151% 2/14/2025Adage Capital Partners GP L.L.C.50,000$407K0.0%N/A3.817% 11/15/2024Anson Funds Management LP983,518$236K0.0%N/A11.151% 11/15/2023Sabby Management LLC96,973$134K0.1%-69.9%3.079% 8/14/2023Anson Funds Management LP36,261$65K0.0%N/A2.833% 5/1/2023Virtu Financial LLC13,433$65K0.0%N/A1.049% (Data available from 1/1/2016 forward) ENSC Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ENSC shares? During the previous two years, the following institutional investors and hedge funds held shares of Ensysce Biosciences shares: Murchinson Ltd. ($358K), Anson Funds Management LP ($236K), and Adage Capital Partners GP L.L.C. ($191K), Sabby Management LLC ($134K).Learn more on Ensysce Biosciences' institutional investors. What percentage of Ensysce Biosciences' stock is owned by institutional investors? 5.63% of Ensysce Biosciences' stock is owned by institutional investors. Learn more on ENSC's institutional investor holdings. Which institutional investors have been buying Ensysce Biosciences' stock? The following institutional investors have purchased Ensysce Biosciences' stock in the last 24 months: Anson Funds Management LP ($1.02M), Murchinson Ltd. ($140K), and Adage Capital Partners GP L.L.C. ($74.71K). How much institutional buying is happening at Ensysce Biosciences? Institutional investors have bought a total of 1,198,229 shares in the last 24 months. This purchase volume represents approximately $4.37M in transactions. Related Companies BIVI Major Shareholders QTTB Major Shareholders MTEX Major Shareholders CARM Major Shareholders BLRX Major Shareholders ERNA Major Shareholders AYTU Major Shareholders LGVN Major Shareholders IMNN Major Shareholders LPCN Major Shareholders This page (NASDAQ:ENSC) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredThe mainstream media is wrong about AI — againThe mainstream media got it wrong … yet again. AI has recently turned the tech world on its head. And th...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ensysce Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ensysce Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
